These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25241119)

  • 41. Emergency reversal of anticoagulation: from theory to real use of prothrombin complex concentrates. A retrospective Italian experience.
    Barillari G; Pasca S; Barillari A; De Angelis V
    Blood Transfus; 2012 Jan; 10(1):87-94. PubMed ID: 22044952
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dosing of 3-factor prothrombin complex concentrate for international normalized ratio reversal.
    Baggs JH; Patanwala AE; Williams EM; Erstad BL
    Ann Pharmacother; 2012 Jan; 46(1):51-6. PubMed ID: 22190253
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fixed Versus Variable Dosing of Prothrombin Complex Concentrate in Vitamin K Antagonist-Related Intracranial Hemorrhage: A Retrospective Analysis.
    Abdoellakhan RA; Miah IP; Khorsand N; Meijer K; Jellema K
    Neurocrit Care; 2017 Feb; 26(1):64-69. PubMed ID: 27052728
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of warfarin-related intracranial hemorrhage: a comparison of prothrombin complex concentrate and recombinant activated factor VII.
    Pinner NA; Hurdle AC; Oliphant C; Reaves A; Lobo B; Sills A
    World Neurosurg; 2010 Dec; 74(6):631-5. PubMed ID: 21492631
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Prothrombin complex concentrate good in warfarin induced hemorrhage. Quick reversal--plasma should be avoided].
    Själander A; Berntorp E; Svensson PJ
    Lakartidningen; 2009 Sep 9-15; 106(37):2278, 2280-1. PubMed ID: 19817161
    [No Abstract]   [Full Text] [Related]  

  • 46. Protocolized use of Factor Eight Inhibitor Bypassing Activity (FEIBA) for the reversal of warfarin induced coagulopathy.
    Htet NN; Barounis D; Knight C; Umunna BP; Hormese M; Lovell E
    Am J Emerg Med; 2020 Mar; 38(3):539-544. PubMed ID: 31176578
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reversal of Warfarin-Associated Major Hemorrhage: Activated Prothrombin Complex Concentrate versus 4-Factor Prothrombin Complex Concentrate.
    Peksa GD; Mokszycki RK; Rech MA; Maynard B; Panos NG; Sweis RT; DeMott JM
    Thromb Haemost; 2020 Feb; 120(2):207-215. PubMed ID: 31837652
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Retrospective evaluation of the clinical use of prothrombin complex concentrate for the reversal of anticoagulation with vitamin K antagonists.
    Cruz JL; Moss MC; Chen SL; Hansen KM; Amerine LB
    Blood Coagul Fibrinolysis; 2015 Jun; 26(4):378-82. PubMed ID: 25688457
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A new kid on the block: Outcomes with Kcentra 1 year after approval.
    Berndtson AE; Huang WT; Box K; Kobayashi L; Godat LN; Smith AM; Weingarten D; Coimbra R
    J Trauma Acute Care Surg; 2015 Dec; 79(6):1004-8. PubMed ID: 26488322
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correction of INR by prothrombin complex concentrate and vitamin K in patients with warfarin related hemorrhagic complication.
    Yasaka M; Sakata T; Minematsu K; Naritomi H
    Thromb Res; 2002 Oct; 108(1):25-30. PubMed ID: 12586128
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis.
    Baker RI; Coughlin PB; Gallus AS; Harper PL; Salem HH; Wood EM;
    Med J Aust; 2004 Nov; 181(9):492-7. PubMed ID: 15516194
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Four-factor prothrombin complex concentrate dose response relationship with INR for warfarin reversal.
    Yohe AS; Livings SE
    Am J Emerg Med; 2019 Aug; 37(8):1534-1538. PubMed ID: 31130370
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fixed- versus variable-dose prothrombin complex concentrate protocol for vitamin K antagonist reversal.
    Bizzell AC; Mousavi MK; Yin E
    Int J Hematol; 2021 Sep; 114(3):334-341. PubMed ID: 34191234
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reversal of elevated international normalized ratios and bleeding with low-dose recombinant activated factor VII in patients receiving warfarin.
    Dager WE; King JH; Regalia RC; Williamson D; Gosselin RC; White RH; Tharratt RS; Albertson TE
    Pharmacotherapy; 2006 Aug; 26(8):1091-8. PubMed ID: 16863486
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of 3 Different Prothrombin Complex Concentrate Regimens for Emergent Warfarin Reversal: PCCWaR Study.
    Dietrich SK; Rowe S; Cocchio CA; Harmon AJ; Nerenberg SF; Blankenship PS
    Ann Pharmacother; 2021 Aug; 55(8):980-987. PubMed ID: 33305592
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of prothrombin complex concentrate in warfarin anticoagulation reversal in the emergency department: a quality improvement study of administration delays.
    Bordeleau S; Poitras J; Marceau D; Breton C; Beaupré P; Archambault PM
    BMC Health Serv Res; 2015 Mar; 15():106. PubMed ID: 25880097
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of the safety and efficacy between 3-factor and 4-factor prothrombin complex concentrates for the reversal of warfarin.
    Kuroski JE; Young S
    Am J Emerg Med; 2017 Jun; 35(6):871-874. PubMed ID: 28161220
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of Fixed-Dose Four-Factor Prothrombin Complex Concentrate for Emergent Warfarin Reversal in Patients with Intracranial Hemorrhage.
    Scott R; Kersten B; Basior J; Nadler M
    J Emerg Med; 2018 Jun; 54(6):861-866. PubMed ID: 29510892
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A protocol for the rapid normalization of INR in trauma patients with intracranial hemorrhage on prescribed warfarin therapy.
    Kalina M; Tinkoff G; Gbadebo A; Veneri P; Fulda G
    Am Surg; 2008 Sep; 74(9):858-61. PubMed ID: 18807678
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 4-Factor Prothrombin Complex Concentrate Administration via Intraosseous Access for Urgent Reversal of Warfarin.
    Peyko V; Shams D; Urbanski R; Noga J
    J Emerg Med; 2019 Jul; 57(1):82-84. PubMed ID: 31060844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.